This undated electron microscope image made available by the US National Institutes of Health in February 2020 shows 2019-nCoV, the novel coronavirus that causes Covid-19. Photo: AP
Chinese trials for Gilead’s antiviral drug to treat coronavirus still far from reaching patient recruitment goals
- Antiviral remdesivir is being trialled as a treatment for the novel coronavirus in 10 hospitals in Wuhan
- Researchers have recruited more than 230 patients for the trials so far, short of the 760 targeted
This undated electron microscope image made available by the US National Institutes of Health in February 2020 shows 2019-nCoV, the novel coronavirus that causes Covid-19. Photo: AP
